Tjoa Thian Song
Keine laufenden Positionen mehr
Karriereverlauf von Tjoa Thian Song
Ehemalige bekannte Positionen von Tjoa Thian Song
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Icon Bioscience, Inc.
 Icon Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Icon Bioscience, Inc. develops and markets ophthalmic pharmaceuticals. It develops specialty pharmaceuticals targeting ophthalmic indications including macular edema, glaucoma, age-related macular degeneration and cataract surgery. The firm's pipeline includes IBI-10090, IBI-20089, IBI-60089, and IBI-80090. The company was founded by Vernon G. Wong and is headquartered in Newark, CA. | Direktor/Vorstandsmitglied | - | - |
| LIQUIDMETAL TECHNOLOGIES, INC. | Direktor/Vorstandsmitglied | 01.01.1996 | - |
Ausbildung von Tjoa Thian Song
| National University of Singapore | Masters Business Admin |
| The University of Texas at Austin | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Singapur | 2 |
Operativ
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sektoral
| Consumer Services | 3 |
| Non-Energy Minerals | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LIQUIDMETAL TECHNOLOGIES, INC. | Non-Energy Minerals |
| Private Unternehmen | 1 |
|---|---|
Icon Bioscience, Inc.
Icon Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Icon Bioscience, Inc. develops and markets ophthalmic pharmaceuticals. It develops specialty pharmaceuticals targeting ophthalmic indications including macular edema, glaucoma, age-related macular degeneration and cataract surgery. The firm's pipeline includes IBI-10090, IBI-20089, IBI-60089, and IBI-80090. The company was founded by Vernon G. Wong and is headquartered in Newark, CA. | Health Technology |
- Börse
- Insiders
- Tjoa Thian Song
- Erfahrung
